Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Clark

Showing results (161-170 of 239) with videos related to

Pageof 24
Sort By:
Genes, Chromosomes & Cancer|August 15, 2015
Genetic and chromosomal alterations in Kenyan Wilms TumorHarold N Lovvorn, Janene Pierce, Jaime Libes, et al.
Urologic Oncology|January 22, 2017
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinomaZachary A Glaser, Harold D Love, Shunhua Guo, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
Molecular Oncology|February 12, 2017
Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumorsDina Polosukhina, Harold D Love, Hernan Correa, et al.
Circulation|February 4, 2010
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation OncologyGlenn N Levine, Anthony V D'Amico, Peter Berger, et al.
The Journal of Urology|September 18, 2009
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomyYakup Kordan, Sam S Chang, Shady Salem, et al.
Urologic Oncology|November 4, 2024
Diagnostic yield of upper tract imaging performed for hematuria screening: Results from a national, privately-insured cohortEric Ballon-Landa, Alex Hannemann, Boris Gershman, et al.
The Journal of Urology|November 16, 2010
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancerJustin R Gregg, Michael S Cookson, Sharon Phillips, et al.
Urology|April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancerChad R Ritch, Chaochen You, Alexandra T May, et al.
Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.
Pageof 24

Showing results (161-170 of 239) with videos related to

Sort By:
Pageof 24
Genes, Chromosomes & Cancer|August 15, 2015
Genetic and chromosomal alterations in Kenyan Wilms TumorHarold N Lovvorn, Janene Pierce, Jaime Libes, et al.
Urologic Oncology|January 22, 2017
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinomaZachary A Glaser, Harold D Love, Shunhua Guo, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
Molecular Oncology|February 12, 2017
Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumorsDina Polosukhina, Harold D Love, Hernan Correa, et al.
Circulation|February 4, 2010
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation OncologyGlenn N Levine, Anthony V D'Amico, Peter Berger, et al.
The Journal of Urology|September 18, 2009
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomyYakup Kordan, Sam S Chang, Shady Salem, et al.
Urologic Oncology|November 4, 2024
Diagnostic yield of upper tract imaging performed for hematuria screening: Results from a national, privately-insured cohortEric Ballon-Landa, Alex Hannemann, Boris Gershman, et al.
The Journal of Urology|November 16, 2010
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancerJustin R Gregg, Michael S Cookson, Sharon Phillips, et al.
Urology|April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancerChad R Ritch, Chaochen You, Alexandra T May, et al.
Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.
Pageof 24